Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

Saved in:
Bibliographic Details
Published inClinical pharmacology and therapeutics Vol. 84; no. 6; p. 679
Main Authors Krishna, R, Bergman, A J, Jin, B, Fallon, M, Cote, J, Van Hoydonck, P, Laethem, T, Gendrano, 3rd, I N, Van Dyck, K, Hilliard, D, Laterza, O, Snyder, K, Chavez-Eng, C, Lutz, R, Chen, J, Bloomfield, D M, De Smet, M, Van Bortel, L M, Gutierrez, M, Al-Huniti, N, Dykstra, K, Gottesdiener, K M, Wagner, J A
Format Journal Article
LanguageEnglish
Published United States 01.12.2008
Subjects
Administration, Oral
Adolescent
Adult
Cholesterol Ester Transfer Proteins - administration & dosage
Cholesterol Ester Transfer Proteins - antagonists & inhibitors
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Humans
Male
Middle Aged
Oxazolidinones - administration & dosage
Oxazolidinones - pharmacokinetics
Oxazolidinones - pharmacology
Reference Values
Risk Factors
Sensitivity and Specificity
Young Adult
Online AccessGet more information

Cover

More Information
ISSN:1532-6535
DOI:10.1038/clpt.2008.109